Showing 10 of 30 recruiting trials for “primary-myelofibrosis”
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
👨⚕️ Rachel B. Salit, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Feb 2021View details ↗
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
👨⚕️ Maria Cancio, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started Nov 2020View details ↗
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
RecruitingNCT02934477 ↗
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
RecruitingNCT02760238 ↗
Myeloproliferative Neoplasms (MPNs) Patient Registry
RecruitingNCT01973881 ↗
Quantitative MRI for Myelofibrosis
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →